AVR

What one share of Anteris Technologies Global holds

Orthopedic, Prosthetic and Surgical Appliances and Supplies

Anteris is a structural heart company dedicated to revolutionizing cardiac care by pioneering science-driven and measurable advancements to restore heart valve patients to healthy function. Our lead product, the DurAVR® THV System, was designed in collaboration with the world’s leading interventional cardiologists and cardiac surgeons to treat aortic stenosis — a potentially life-threatening condition resulting from a narrowing of the aortic valve.

Anteris Technologies Global’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.

Per-share figures
Sales$0.04
Profit−$1.62
Capex (buildings and equipment)$0.03
Free cash flow−$1.38
Cash and investments$2.57
Debt$0.00
Book value$2.58

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2024$0.13−$3.77$0.11−$3.14—$1.75
2025$0.05−$2.55$0.05−$2.16—−$0.00

Common questions about Anteris Technologies Global

How much does one share of Anteris Technologies Global earn?

Over the last 12 months, Anteris Technologies Global lost $1.62 for each share on $0.04 of sales.

Does Anteris Technologies Global pay a dividend?

Anteris Technologies Global didn’t pay a dividend over the last 12 months, according to its SEC filings.

What is Anteris Technologies Global’s book value per share?

Anteris Technologies Global’s book value is $2.58 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.

How much cash and debt does each share of Anteris Technologies Global have?

Each share of Anteris Technologies Global has $2.57 of cash and investments and $0.00 of debt, as of June 30, 2026.

What is Anteris Technologies Global’s free cash flow per share?

−$1.38 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.